Select your language/region

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes

18.3

SEK

-1.88

percent

Q-linea as an investment

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes

18.3

SEK

-1.88

percent

Redeye Theme: Medtech Presentation

Our CEO, Stuart Gander, presented at the Redeye Theme: Medtech event on May 8th, 2025.

You can watch the presentation here.

Life Science Day Presentation

Our CEO Stuart Gander presented at Life Science Day courtesy of Aktiespararna on the 17th of April 2024.

Watch the presentation here:

 

 

Future-proof Healthcare

One of our founders, Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.

 

 

Press releases

Regulatory press release

2026/05/29

Annika Blondeau Henriksson new interim CFO

Regulatory press release

2026/05/27

BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)

Regulatory press release

2026/04/30

Interim report January – March 2026
Growing recurring income and increased market activity within rapid ASTFirst quarter: 1 January–31 March 2026Income from sales of consumables…
Read more >

Keep up to date – subscribe

Christer Samuelsson

Investor Relations

Phone: +46 18 444 36 10

Mobile: +46 70 600 15 20

christer.samuelsson@qlinea.com

. . .
The share

Information about Q-linea stock price and trading volume